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  Various immunological inhibitory factors were found in patients with malignant diseases． The
fiz－microglobulin （P2－MG） was synthesized by many kinds of nuclear cells and malignant human
cells； and， this protein had a structual relationship to immunoglobulins and HLA antigen． ln the
present study， we measured the serum fi2－MG of 12 control subjects and 45 patients with’ urinary
bladder carcinoma havipg nermal renal function by radioimmunoassay． The serum B2－MG con－
centration was eleVated in high grade and・high stage patients． But the difference was not significant
between control subjects and low grade or low stage patients． The level of B2－MG was markedly
decreased after operation in high grade and high stage groups．
 ， There was a correlation between B2－MG concentration ． and phytohemagglutinin－induced lympho－
cyte blastogenesis in the patients． lt is suggested that B2－MG might be effective in augmenting the
cellular immune respOnse in patients with urinary bladder carcinoma． ’
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Fig． 1． Comparison of serum P2－MG between
    control subjects and patients with
    bladder carcinoma．
    control low grade high grade
Fig． 2． Cornparison of serum P2－MG between
    control subjects and low or high grade





























control low． stage high stage
Fig． 3． Comparison of serum B2－MG between
    control subjects and low or high stage


















Table 1． Comprison of serum P2－MG in
    patients with bladder carcinoma
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    before after
Fig． 4． Comparison of serum B2－MG in low
    grade bladder carcinoma patients
    before and after operation．
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Fig． 5． Comparison of seruin P2－MG in high
    grade bladder carcinoma patients before


















Fig． 6． Comparison of serum P2－MG in low
    stage bladder carcinoma patients before































Fig． 7， Comparison of serum B2－MG in high
    stage bladder carcinoma patients before




















































      1．0 2，0 3．0 4，0 rs2－MG （pg／mD
Fig． 8． Correlation Tr cell population ’and serum P2－MG in patients
    with low grade bladder carcinoma’．
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Correlation Tr cell population and serum P2－MG in patients
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Fig． 10． Correlation serum P2－MG and PHA－induced blastogenesis （S．1．）
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